MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • Noticias
  • Store
  • Corredores
  • Descargar
  • Calendario económico
  • Señales Comerciales
  • WebTerminal
  • English English
  • Русский Русский
  • 中文 中文
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
DiaMedica Therapeutics Inc. Common Stock

DMAC

#2642
DiaMedica Therapeutics Inc. Common Stock
7.95
-3.05%
Sector:
Básica:
Profit Currency:
Rango diario
7.95
7.95
Rango anual
3.19
10.42
Cambio diario
-3.05%
Monthly Change
-10.17%
6 month change
+31.84%
Cambio anual
+23.26%
Cierres anteriores
8.20
Open
7.95
Bid
Ask
Low
7.95
High
7.95
Volumen
50
  1. Markets
  2. Acciones
  3. Atención Sanitaria
  4. DMAC
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

Noticias

Investing Investing
DMAC
2026.01.22
Cantor Fitzgerald reitera calificación Overweight para acciones de DiaMedica
Investing Investing
DMAC
2026.01.22
Cantor Fitzgerald reitera calificación de Sobreponderación para acciones de DiaMedica
Investing Investing
DMAC
2026.01.22
Cantor Fitzgerald reiterates Overweight rating on DiaMedica stock
Investing Investing
DMAC
2025.12.18
DiaMedica realizará estudio adicional para tratamiento de preeclampsia
Investing Investing
DMAC
2025.12.18
DiaMedica to conduct additional study for preeclampsia treatment
Investing Investing
CSCO PAAS ICL CRWS DGII
2025.11.11
Cisco, Flutter, Manulife and more set to report earnings Wednesday
Investing Investing
DMAC
2025.10.30
TD Cowen inicia cobertura de DiaMedica Therapeutics con calificación de Compra
Investing Investing
DMAC
2025.10.30
TD Cowen inicia cobertura de DiaMedica Therapeutics con calificación de Compra
Investing Investing
DMAC
2025.10.30
DiaMedica Therapeutics stock initiated with Buy rating at TD Cowen
Seeking Alpha Seeking Alpha
AESI GEHC MSFT ET ELV
2025.10.01
Tracking Leon Cooperman’s ~$3B Omega Advisors Portfolio – Q2 2025 Update
Zacks Zacks
DMAC
2025.09.17
DiaMedica Therapeutics, Inc. (DMAC) is a Great Momentum Stock: Should You Buy?
Zacks Zacks
DMAC
2025.09.09
After Golden Cross, DiaMedica Therapeutics, Inc. (DMAC)'s Technical Outlook is Bright

Markets

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Charts & Ideas

  • Ideas comerciales
  • Ideas ilustrativas
  • Gráfico

MQL5 Community

  • Market
  • Señales
  • Foro
  • Artículos
  • CodeBase

Noticias

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Corredores

  • Todos los brókeres
  • Fórex
  • Acciones
  • Metales
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Información y contacto Legal
Copyright 2000-2026, MetaQuotes Ltd